Fourth Year PhD Candidate in the Rutgers Cellular and Molecular Pharmacology PhD program, with a concentration in Cancer Biology. Working under the direction of Dr. Suzie Chen. My current project is studying the long-term therapeutic consequences of an immune checkpoint blockade antibody, anti-PD-1 and a glutamatergic signaling inhibitor, Troriluzole in a spontaneous melanoma prone mouse model. This combination is currently under clinical investigation (NCT03229278). My study aims to develop a clinically relevant mouse model to study metastatic melanoma as well as characterize the mechanism of action of this combination. This model will allow me to identify clinically relevant prognostic biomarker(s) for treatment response. I have received the New Jersey Cancer Commission Pre-Doctoral fellowship for this project.
New Jersey Cancer Commission Pre-Doctoral Fellowship
New Jersey Cancer Commission- New Jersey Department of Health
Received the New Jersey Cancer Commission Pre-Doctoral Fellowship for my doctoral dissertation titled, Preclinical Study Using Trigriluzole and anti-PD-1 in a Spontaneous Melanoma Prone Mouse-Model.
Molecular Biosciences Excellence Fellowship
Rutgers University School of Graduate Studies
Highest Honors awarded for my Undergraduate Honors Thesis
Rutgers University Department of Molecular Biology and Biochemistry
Aresty Research Center Undergraduate Research Fellowship
Rutgers University
Summer Research Fellowship
Rutgers University- Earnest Mario School of Pharmacy